Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...

Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment landscape for patients with metabolic dysfunction-associated steatohepatitis ...

Sam and Joe discuss the MASH unit that is the Cleveland Cavaliers and if there is any hope of the East's number one seed ...

Target RWE, a leader in modern clinical evidence generation for complex diseases, today announced its presentations and strategic contributions at the EASL Congress 2025 in Amsterdam, Netherlands.

AMSTERDAM — A once daily, 50 mg dose of efruxifermin reduced fibrosis at 96 weeks in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH) compared with ...

ESA astronaut Samantha Cristoforetti delivered video - Technique shows how to dispose trash on the International Space ...

Source: Malaria cases in Mash West increase – herald Conrad Mupesa-Mashonaland West Bureau MASHONALAND West Province is ...

The publication reports results from the 96-week SYMMETRY study evaluating the efficacy and safety of Akero's lead FGF21 ...

Abdul Carter wasn't able to secure No. 56, so he took No. 51. However, some have criticized how the whole thing was handled ...

The distilleries that populate the state have offerings for those who love history, nature, and of course the liquor.

In this week's look at the best of the fantasy baseball waiver wire, John Laghezza says now is the time to add Cubs prospect ...